{"DataElement":{"publicId":"5778733","version":"1.1","preferredName":"Patient Neuroblastoma Disease or Disorder Assignment Group Type","preferredDefinition":"Information that indicates patient's assignment to neuroblastoma disease group type.","longName":"Pt_NBL_Ds_Grp_Tp","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"5774022","version":"1","preferredName":"Patient Neuroblastoma Disease or Disorder Assignment","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._A neuroblastic tumor characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._An allotting or an appointment to a particular person or use, or for a particular time or object.","longName":"2233604v1.0:5774020v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5774020","version":"1","preferredName":"Neuroblastoma Disease or Disorder Assignment","preferredDefinition":"A neuroblastic tumor characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:An allotting or an appointment to a particular person or use, or for a particular time or object.","longName":"C3270:C2991:C25426","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroblastoma","conceptCode":"C3270","definition":"A malignant neuroblastic tumor characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assignment","conceptCode":"C25426","definition":"An allotting or an appointment to a particular person or use, or for a particular time or object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D132939-27F5-3938-E053-F662850A352F","latestVersionIndicator":"Yes","beginDate":"2017-04-13","endDate":null,"createdBy":"CHANGP","dateCreated":"2017-04-13","modifiedBy":"ONEDATA","dateModified":"2017-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D132939-2806-3938-E053-F662850A352F","latestVersionIndicator":"Yes","beginDate":"2017-04-13","endDate":null,"createdBy":"CHANGP","dateCreated":"2017-04-13","modifiedBy":"ONEDATA","dateModified":"2017-04-13","changeDescription":"ANBL1531-PDC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5778726","version":"1.1","preferredName":"Neuroblastoma Group Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"5778726v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"6","valueDescription":"Disease Progression NMYC Gene Amplification INRG Stage L1 To INRG Stage M","ValueMeaning":{"publicId":"5778727","version":"1","preferredName":"Disease Progression NMYC Gene Amplification INRG Stage L1 To INRG Stage M","longName":"5778727","preferredDefinition":"The worsening of a disease over time.: A molecular genetic abnormality indicating the presence of multiple copies of the MYCN gene.: Locoregional neuroblastoma without image defined risk factors (IDRFs).: Used as a function word to indicate direction, purpose, or movement.: Neuroblastoma with distant metastatic disease (except MS).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Progression","conceptCode":"C17747","definition":"A process that manifests as the worsening of a disease over time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"NMYC Gene Amplification","conceptCode":"C36673","definition":"A molecular genetic abnormality indicating the presence of multiple copies of the MYCN gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"INRG Stage L1","conceptCode":"C133428","definition":"Locoregional neuroblastoma without image defined risk factors (IDRFs).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"INRG Stage M","conceptCode":"C133430","definition":"Neuroblastoma with distant metastatic disease (except MS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D9C2021-83A9-34A1-E053-F662850A50F1","latestVersionIndicator":"Yes","beginDate":"2017-04-20","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A2CF71C-165D-47C9-E053-F662850A8652","beginDate":"2017-04-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-11-08","modifiedBy":"ONEDATA","dateModified":"2018-11-08","deletedIndicator":"No"},{"value":"5","valueDescription":"Disease Progression INRG Stage MS INRG Stage L2 INRG Stage L1 To INRG Stage M","ValueMeaning":{"publicId":"5778728","version":"1","preferredName":"Disease Progression INRG Stage MS INRG Stage L2 INRG Stage L1 To INRG Stage M","longName":"5778728","preferredDefinition":"The worsening of a disease over time.: INRG stage L1 or L2 neuroblastoma with metastatic disease confined to the skin and/or liver and/or bone marrow.: Locoregional neuroblastoma with one or more image defined risk factors (IDRFs).: Locoregional neuroblastoma without image defined risk factors (IDRFs).: Used as a function word to indicate direction, purpose, or movement.: Neuroblastoma with distant metastatic disease (except MS).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Progression","conceptCode":"C17747","definition":"A process that manifests as the worsening of a disease over time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"INRG Stage MS","conceptCode":"C133431","definition":"INRG stage L1 or L2 neuroblastoma with metastatic disease confined to the skin and/or liver and/or bone marrow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"INRG Stage L2","conceptCode":"C133429","definition":"Locoregional neuroblastoma with one or more image defined risk factors (IDRFs).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"INRG Stage L1","conceptCode":"C133428","definition":"Locoregional neuroblastoma without image defined risk factors (IDRFs).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"INRG Stage M","conceptCode":"C133430","definition":"Neuroblastoma with distant metastatic disease (except MS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D9C2021-83D3-34A1-E053-F662850A50F1","latestVersionIndicator":"Yes","beginDate":"2017-04-20","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A2CF71C-1667-47C9-E053-F662850A8652","beginDate":"2017-04-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-11-08","modifiedBy":"ONEDATA","dateModified":"2018-11-08","deletedIndicator":"No"},{"value":"4","valueDescription":"INRG Stage L2 NMYC Gene Amplification","ValueMeaning":{"publicId":"5778729","version":"1","preferredName":"INRG Stage L2 NMYC Gene Amplification","longName":"5778729","preferredDefinition":"Locoregional neuroblastoma with one or more image defined risk factors (IDRFs).: A molecular genetic abnormality indicating the presence of multiple copies of the MYCN gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"INRG Stage L2","conceptCode":"C133429","definition":"Locoregional neuroblastoma with one or more image defined risk factors (IDRFs).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"NMYC Gene Amplification","conceptCode":"C36673","definition":"A molecular genetic abnormality indicating the presence of multiple copies of the MYCN gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D9C2021-83FB-34A1-E053-F662850A50F1","latestVersionIndicator":"Yes","beginDate":"2017-04-20","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A2CF71C-1671-47C9-E053-F662850A8652","beginDate":"2017-04-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-11-08","modifiedBy":"ONEDATA","dateModified":"2018-11-08","deletedIndicator":"No"},{"value":"2","valueDescription":"INRG Stage M Unknown Or Negation NMYC Gene Amplification","ValueMeaning":{"publicId":"5778731","version":"1","preferredName":"INRG Stage M Unknown Or Negation NMYC Gene Amplification","longName":"5778731","preferredDefinition":"Neuroblastoma with distant metastatic disease (except MS).: Not known, not observed, not recorded, or refused.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: An operation in which a term denies or inverts the meaning of another term or construction.: A molecular genetic abnormality indicating the presence of multiple copies of the MYCN gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"INRG Stage M","conceptCode":"C133430","definition":"Neuroblastoma with distant metastatic disease (except MS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"NMYC Gene Amplification","conceptCode":"C36673","definition":"A molecular genetic abnormality indicating the presence of multiple copies of the MYCN gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D9C2021-844E-34A1-E053-F662850A50F1","latestVersionIndicator":"Yes","beginDate":"2017-04-20","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A2CF71C-167B-47C9-E053-F662850A8652","beginDate":"2017-04-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-11-08","modifiedBy":"ONEDATA","dateModified":"2018-11-08","deletedIndicator":"No"},{"value":"1","valueDescription":"INRG Stage M NMYC Gene Amplification","ValueMeaning":{"publicId":"5778732","version":"1","preferredName":"INRG Stage M NMYC Gene Amplification","longName":"5778732","preferredDefinition":"Neuroblastoma with distant metastatic disease (except MS).: A molecular genetic abnormality indicating the presence of multiple copies of the MYCN gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"INRG Stage M","conceptCode":"C133430","definition":"Neuroblastoma with distant metastatic disease (except MS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"NMYC Gene Amplification","conceptCode":"C36673","definition":"A molecular genetic abnormality indicating the presence of multiple copies of the MYCN gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D9C2021-8476-34A1-E053-F662850A50F1","latestVersionIndicator":"Yes","beginDate":"2017-04-20","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A2CF71C-1685-47C9-E053-F662850A8652","beginDate":"2017-04-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-11-08","modifiedBy":"ONEDATA","dateModified":"2018-11-08","deletedIndicator":"No"},{"value":"3","valueDescription":"INRG Stage MS NMYC Gene Amplification","ValueMeaning":{"publicId":"5778730","version":"1","preferredName":"INRG Stage MS NMYC Gene Amplification","longName":"5778730","preferredDefinition":"INRG stage L1 or L2 neuroblastoma with metastatic disease confined to the skin and/or liver and/or bone marrow.: A molecular genetic abnormality indicating the presence of multiple copies of the MYCN gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"INRG Stage MS","conceptCode":"C133431","definition":"INRG stage L1 or L2 neuroblastoma with metastatic disease confined to the skin and/or liver and/or bone marrow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"NMYC Gene Amplification","conceptCode":"C36673","definition":"A molecular genetic abnormality indicating the presence of multiple copies of the MYCN gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D9C2021-8423-34A1-E053-F662850A50F1","latestVersionIndicator":"Yes","beginDate":"2017-04-20","endDate":null,"createdBy":"HLAINGY","dateCreated":"2017-04-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A2CF71C-168F-47C9-E053-F662850A8652","beginDate":"2017-04-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-11-08","modifiedBy":"ONEDATA","dateModified":"2018-11-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A2CF71C-1647-47C9-E053-F662850A8652","latestVersionIndicator":"Yes","beginDate":"2017-04-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-11-08","modifiedBy":"COBARRUBIAK","dateModified":"2018-11-08","changeDescription":"11/8/18 - versioned VD to add max length. bsm","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What is patient's disease gro","type":"Preferred Question Text","description":"What is patient's disease group?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A2D0AF8-D6EB-4161-E053-F662850A16E0","latestVersionIndicator":"Yes","beginDate":"2017-04-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-11-08","modifiedBy":"MAESKEB","dateModified":"2018-11-08","changeDescription":"Workflow and Registration Status Changed per Brenda Duggan; 05.16.18 11/8/18 - versioned CDE due to adding max length to the VD. bsm","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}